Advarra Publishes 2024 Site-Sponsor-CRO Collaboration Survey Results to Improve Clinical Research

1 year ago

Survey identifies three barriers to stakeholder collaboration, including communications, staffing, and technology, and five key actions to improve alignment. COLUMBIA,…

Canopy to be Highlighted in Two Studies at ASH 2024

1 year ago

Research Shows Potential to Improve Time on Treatment and Detection of High-Risk Toxicities for Blood Cancer Patients Using the Canopy…

15% of the World’s Most Influential Companies Fail to Protect Children, Raising Urgent Concerns

1 year ago

STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- Global Child Forum, in partnership with Boston Consulting Group (BCG), today released its largest…

WellNow Urgent Care Announces Return to Excellus BlueCross BlueShield Network

1 year ago

Excellus BCBS insurance will be accepted at WellNow Urgent Care effective November 15 EAST SYRACUSE, N.Y., Nov. 12, 2024 /PRNewswire/…

CMS Selected Belle.ai to Present its AI for Dermatology in the First Artificial Intelligence Demo Day

1 year ago

Attended by Over 800 U.S. Department of Health and Human Services Personnel CAMBRIDGE, Mass., Nov. 12, 2024 /PRNewswire/ -- The…

Revolutionizing Patient Care: Clinical Notes AI Transforms Behavioral Healthcare Documentation

1 year ago

Innovative Solutions Enhance Efficiency, Improve Patient Care, and Alleviate Clinician Burnout SAN DIEGO, Nov. 12, 2024 /PRNewswire/ -- Clinical Notes…

Better Safe Than Stereo

1 year ago

Canadian Women's Foundation highlights gender-based violence with release of AwarePod, the first earbud designed for women TORONTO, Nov. 12, 2024…

How Brevel Implements First-Of-A-Kind (FOAK) Model for Its Microalgae Protein

1 year ago

The start-up secures long-term off-take agreements as well as joint ventures with partners KIRYAT GAT, Israel, Nov. 12, 2024 /PRNewswire/…

Formation Bio collaborates with Sanofi and OpenAI to Introduce Muse, a first of its kind AI tool to accelerate patient recruitment in drug development

1 year ago

PARIS and NEW YORK and SAN FRANCISCO, Nov. 12, 2024 /PRNewswire/ -- Today, Formation Bio, together with OpenAI and Sanofi, introduced…

Compugen Reports Third Quarter 2024 Results

1 year ago

Clinical data presented at SITC 2024 demonstrated COM701 (anti-PVRIG) mediated anti-tumor activity with durable responses and good tolerability profile in tumors…